Clinical Trial Update: Early Check: Expanded Screening in Newborns

View source ↗

Summary

An update on an ongoing clinical trial (NCT03655223) evaluating expanded newborn screening under the Early Check program, with enrollment by invitation.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Adrenoleukodystrophy
• Cystic Fibrosis
• Duchenne Muscular Dystrophy
• Fragile Syndrome
• Maple Syrup Urine Disease
• Medium-chain Acyl-coa Dehydrogenase Deficiency
• Phenylketonuria
• Spinal Muscular Atrophy

Snippet

Sponsor: RTI International | Conditions: Spinal Muscular Atrophy, Fragile X Syndrome | Status: ENROLLING_BY_INVITATION